| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 06/23/2011 | US20110152199 Cdca1 peptide and pharmaceutical agent comprising the same |
| 06/23/2011 | US20110152191 Natriuretic polypeptides with unique pharmacologic profiles |
| 06/23/2011 | US20110152180 Bioactive pentapeptides from rice bran and use thereof |
| 06/23/2011 | US20110152178 Prophylactic or therapeutic agent for influenza virus infection |
| 06/23/2011 | US20110151494 Methods and materials for monitoring myeloma using quantitative mass spectrometry |
| 06/23/2011 | US20110150917 Small Cationic Antimicrobial Peptides |
| 06/23/2011 | US20110150916 Compositions and methods for treatment of group a streptococci |
| 06/23/2011 | US20110150914 Compositions and methods for dengue virus (dv) treatment and vaccination |
| 06/23/2011 | US20110150849 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/23/2011 | US20110150830 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 06/23/2011 | US20110150780 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 06/23/2011 | US20110150764 Stroke-tageting peptide and use thereof |
| 06/23/2011 | CA2784624A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof |
| 06/23/2011 | CA2782977A1 Tmem22 peptides and vaccines including the same |
| 06/23/2011 | CA2782131A1 Peptide |
| 06/22/2011 | EP2336185A1 Anti- alpha v beta 6 antibodies |
| 06/22/2011 | EP2336165A1 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/22/2011 | EP2336108A1 Hybrid tripyrrole-octaarginine compounds and their use as medicament in the treatment of cancer and microbial illnesses |
| 06/22/2011 | EP2334337A1 Polymer conjugates of opioid growth factor peptides |
| 06/22/2011 | EP2334326A2 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 06/22/2011 | EP2334314A1 Process for the preparation of pramlintide |
| 06/22/2011 | EP1680507B1 Bacterial expression of protease inhibitors and variants thereof |
| 06/22/2011 | DE102009055015A1 Hefe-Sekretionssystem auf Basis einer Signalsequenz aus der Hydrophobin 1-Gensequenz von Trichoderma reesei Yeast secretion system on the basis of a signal sequence of the hydrophobin 1 gene sequence of Trichoderma reesei |
| 06/22/2011 | CN1739029B Prion protein ligands and methods of use |
| 06/22/2011 | CN1560078B Tumor antigen based on products of the tumor suppressor gene WT1 |
| 06/22/2011 | CN102105487A CRKL targeting peptides |
| 06/22/2011 | CN102105486A Peptidylarginine deiminase (PAD) inhibitors |
| 06/22/2011 | CN102105485A Selective caspase inhibitors and uses thereof |
| 06/22/2011 | CN102101886A Variable-conformation recombinant interferon crystal, and three-dimensional structure and use thereof |
| 06/22/2011 | CN101434650B Bursa pentapeptide, deriving peptide thereof and use thereof |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964557 Administering adiponectin; inhibitory effect of adiponectin on choroidal angiogenesis or choroidal neovascularization |
| 06/21/2011 | US7964554 Polypeptide that binds anti-histone H1 antibody |
| 06/21/2011 | US7964536 Neoepitope detection of disease using protein arrays |
| 06/21/2011 | US7964366 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/16/2011 | WO2011071927A2 Treatments for gastrointestinal disorders |
| 06/16/2011 | WO2011071280A2 Intracelluar targeting bipodal peptide binder |
| 06/16/2011 | WO2011071279A2 Bpb-based cargo delivery system |
| 06/16/2011 | WO2011071099A1 Anticancer anti-mortalin peptide antibodies |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011071021A1 Tag peptide |
| 06/16/2011 | WO2011070364A1 Novel cyclic peptides |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2010121013A3 Molecularly imprinted polymers for detecting hiv-1 |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use |
| 06/16/2011 | US20110144022 Anti-Angiogenic Peptide |
| 06/16/2011 | US20110144014 Cytokine receptor modulators and uses thereof |
| 06/16/2011 | US20110144005 Novel cyclic peptides |
| 06/16/2011 | US20110144001 Highly bridged peptides from actinomadura namibiensis |
| 06/16/2011 | US20110144000 Antimicrobial polypeptide |
| 06/16/2011 | US20110143998 Identification and use of peptide inhibitors of protein synthesis |
| 06/16/2011 | US20110143993 Endothelial basement membrane targeting peptide ligands |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110143954 Gamma-secretase substrate and methods of use |
| 06/16/2011 | US20110143443 Isolsted Monoclonal - Associated Protein Tau and Kit |
| 06/16/2011 | US20110143384 Methods of peptide modification |
| 06/16/2011 | US20110143367 Antibodies against april as biomarkers for early prognosis of lymphoma patients |
| 06/16/2011 | US20110142895 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 06/16/2011 | US20110142870 Bacillus anthracis antigens, vaccine compositions, and related methods |
| 06/16/2011 | US20110142868 Peptidylarginine Deiminase (PAD) Inhibitors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142866 Peptide analogues and conjugates thereof |
| 06/16/2011 | US20110142865 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142864 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 06/16/2011 | US20110142843 Fetal polypeptides from human liver |
| 06/16/2011 | CA2782898A1 Novel cyclic peptides |
| 06/16/2011 | CA2781883A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/15/2011 | EP2333550A2 Polypeptide markers for the diagnosis of bladder cancer |
| 06/15/2011 | EP2333060A2 HLA-binding peptides, DNA fragments encoding the same and recombinant vectors |
| 06/15/2011 | EP2332965A1 Peptide antibiotics and methods for making same |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332559A1 Peptides for the treatment of pain |
| 06/15/2011 | EP2332512A1 Method for enhancing effects of colorants and conditioners |
| 06/15/2011 | EP2331708A1 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 06/15/2011 | EP2331564A2 Methods of treating inflammation |
| 06/15/2011 | EP2331563A1 Peptidic and peptidomimetic compounds for regulating autophagy |
| 06/15/2011 | EP2331562A2 Peptides presenting an epitope of an a domain of factor h binding protein and methods of use |
| 06/15/2011 | EP2331561A1 Libraries of peptide conjugates and methods for making them |
| 06/15/2011 | EP2331124A1 T-cell antigen peptide from allergen for stimulation of il-10 production |
| 06/15/2011 | EP2331048A1 Oligomeric biosurfactants in dermatocosmetic compositions |
| 06/15/2011 | EP1881008B1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 06/15/2011 | EP1583562B1 Angiopep-1, related compounds, and uses thereof |
| 06/15/2011 | CN102099372A Anti-amyloid immunogenic compositions, methods and uses |
| 06/15/2011 | CN102099370A Anticancer compounds |
| 06/15/2011 | CN102093471A Angiotensin I transferase inhibitor and preparation method and application thereof |
| 06/15/2011 | CN101412750B Bursin specific binding peptide and screening method thereof |
| 06/15/2011 | CN101195654B Solid phase synthesis technique for melanotan-II |
| 06/14/2011 | US7960508 A peptide fragment containing selenocysteine has a lowered toxicity than selenocystine, exhibits a cytotoxicity-inhibitory activity; screening a drug having cytotoxicity-inhibitory activity by utilizing a cellular sudden death phenomenon in a cell culture system; glutathione peroxidase activity |
| 06/14/2011 | US7960348 Metastin derivatives and use thereof |
| 06/14/2011 | US7960336 Composition for long-acting peptide analogs |
| 06/14/2011 | CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 06/09/2011 | WO2011067933A1 Mybl2 peptides and vaccines containing the same |
| 06/09/2011 | WO2011067920A1 Imp-3 oligopeptides and vaccines including the same |
| 06/09/2011 | WO2011067624A1 Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer |
| 06/09/2011 | WO2011066869A1 Beta-hairpin peptidomimetics |
| 06/09/2011 | WO2010052559A8 Cycloundecadepsipeptide compounds and use of said compounds as a medicament |
| 06/09/2011 | US20110136741 Dicarba-analogues of octreotide |